BREAKING NEWS

Novartis

Showing 6 results for 'Novartis'

Articles (x) Videos (x)

Business

Novartis and GSK swap assets in pharma industry reshape

There has been a major shake-up in the drugmaking world. Swiss firm Novartis is selling its animal medicines division and swapping assets with

There has been a major shake-up in the drugmaking world. Swiss firm Novartis is selling its animal medicines division and swapping assets with

News

Novartis says it will stick with drug development in India

Swiss drugs maker Novartis says its Indian subsidiary will continue to file patents for new drugs in India despite the rejection of its plea for

Swiss drugs maker Novartis says its Indian subsidiary will continue to file patents for new drugs in India despite the rejection of its plea for

News

India rejects Novartis drug patent

India’s Supreme Court has rejected a request by Swiss drug-maker Novartis to patent an updated version of its cancer drug Glivec. Glivec costs

India’s Supreme Court has rejected a request by Swiss drug-maker Novartis to patent an updated version of its cancer drug Glivec. Glivec costs

News

Protesters say cheap drugs threatened by India court battle

The Indian headquarters of Swiss drugmaker Novartis has been surrounded by protesters demanding the right to cheap drugs. Several people living

The Indian headquarters of Swiss drugmaker Novartis has been surrounded by protesters demanding the right to cheap drugs. Several people living

News

Spain and Germany also ban Novartis flu vaccines

Italy, Switzerland and Austria have banned the sale of anti-flu vaccines made by Swiss drugmaker Novartis. The move follows a report into small

Italy, Switzerland and Austria have banned the sale of anti-flu vaccines made by Swiss drugmaker Novartis. The move follows a report into small

Business

Novartis cuts more jobs on drug setback

In its latest round of job cuts, Novartis is to axe nearly 2,000 of its US workforce, mostly from the sales division. The Swiss drugmaker is

In its latest round of job cuts, Novartis is to axe nearly 2,000 of its US workforce, mostly from the sales division. The Swiss drugmaker is